Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.42 |
| ▸ | TNIK | Q9UKE5 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11883401 | 0.86 | PYGL (0.46) | ALDH1A1HPGDMAOBGAAKMT2A | |
| SCHEMBL2590631 | 0.83 | ALDH1A1 (0.75) | ALDH1A1HPGDGAAKMT2A | |
| SCHEMBL30356244 | 0.83 | ALDH1A1 (0.75) | ALDH1A1HPGDGAAKMT2A | |
| SCHEMBL6114130 | 0.79 | PYGL (0.52) | ALDH1A1HPGDEPHX1KMT2AKDM4E | |
| SCHEMBL28047546 | 0.79 | ALDH1A1 (0.47) | ALDH1A1HPGDEPHX1GAAKMT2A | |
| SCHEMBL17085567 | 0.79 | ALDH1A1 (0.51) | ALDH1A1HPGDEPHX1GAAKMT2A | |
| SCHEMBL29557119 | 0.78 | MAOB (0.55) | ALDH1A1HPGDMAOBKMT2AESR1 | |
| SCHEMBL30810230 | 0.78 | ALDH1A1 (0.46) | ALDH1A1HPGDEPHX1GAAKMT2A | |
| SCHEMBL7938081 | 0.77 | MAOB (0.59) | ALDH1A1HPGDMAOBGAAKMT2A | |
| SCHEMBL14782205 | 0.77 | HSD17B1 (0.57) | ALDH1A1MAOBEPHX1GAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250186309-A1 | DENTAL CURABLE COMPOSITION AND DENTAL KIT | KURARAY NORITAKE DENTAL INC. (JP) | 2025-06-12 | — | — | US | disclosed |
| EP-4413968-A1 | CURABLE DENTAL COMPOSITION AND DENTAL KIT | Kuraray Noritake Dental Inc. (JP) | 2024-08-14 | — | — | EP | disclosed |
| WO-2023058773-A1 | CURABLE DENTAL COMPOSITION AND DENTAL KIT | クラレノリタケデンタル株式会社 | 2023-04-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250186309-A1 | DENTAL CURABLE COMPOSITION AND DENTAL KIT | KIT, DNMT3L, CDK6 | ALDH1A1 2887/4885HPGD 3943/4885MAOB 4158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.